Annexin A9 Is a Periplakin Interacting Partner in Membrane-Targeted Cytoskeletal Linker Protein Complexes ⇑ Veronika Boczonadi 1, Arto Määttä

Total Page:16

File Type:pdf, Size:1020Kb

Annexin A9 Is a Periplakin Interacting Partner in Membrane-Targeted Cytoskeletal Linker Protein Complexes ⇑ Veronika Boczonadi 1, Arto Määttä View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector FEBS Letters 586 (2012) 3090–3096 journal homepage: www.FEBSLetters.org Annexin A9 is a periplakin interacting partner in membrane-targeted cytoskeletal linker protein complexes ⇑ Veronika Boczonadi 1, Arto Määttä School of Biological and Biomedical Sciences, Durham University, DH1 3LE Durham, United Kingdom article info abstract Article history: Periplakin regulates keratin organisation and participates in the assembly of epidermal cornified Received 3 April 2012 envelopes. A proteomic approach identified annexin A9 as a novel interacting partner for periplakin Revised 13 July 2012 N-terminus. The presence of annexin A9 in complexes with periplakin was confirmed by immuno- Accepted 16 July 2012 blotting of proteins immunoprecipitated by anti-HA or anti-annexin A9 antibodies. Both endoge- Available online 24 July 2012 nous and GFP-tagged annexin A9 co-localise with endogenous periplakin and transfected Edited by Gianni Cesareni periplakin N-terminus at MCF-7 cell borders and aggregate after Okadaic acid treatment. Annexin A9 and periplakin co-localise in the epidermis and annexin A9 is up-regulated in differentiating keratinocytes, but the epidermal annexin A9 expression does not require periplakin. Keywords: Periplakin Annexin Structured summary of protein interactions: Epidermis Annexin-9 physically interacts with Periplakin by anti bait co-immunoprecipitation (View interaction) Epithelia Periplakin physically interacts with Annexin-9 by anti tag co-immunoprecipitation (View Interaction: 1, 2) Co-immunoprecipitation Periplakin and Annexin-9 colocalize by fluorescence microscopy (View Interaction: 1, 2, 3) Epidermal barrier Keratin-8 and Periplakin colocalize by fluorescence microscopy (View interaction) Ó 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved. 1. Introduction an initial scaffold under the plasma membrane upon which a large number of small proteins such as loricrin gets deposited and cross- Periplakin is a member of the plakin family of cytoskeletal linker linked [7,8]. Periplakin is also a major cross-linking platform for the proteins that connect intermediate filaments to actin and microtu- ceramide lipids that replace membrane phospholipids at the stra- bule cytokeletons and to cell adhesion junctions. Periplakin shows a tum corneum [9]. Even though periplakin gene targeted mice do restricted tissue distribution, including both stratified and simple not show a barrier defect [10], the ablation of the all three scaffold epithelial tissues and the brain. In the epidermis of the skin, peripla- proteins, periplakin, envoplakin and involucrin, results in impaired kin expression is upregulated upon keratinocyte differentiation and barrier function and immune cell infiltration to the epidermis [7]. the protein has been shown to associate with desmosomes, cortical The N-terminus of periplakin shares the conserved structure of actin networks and the plasma membrane surrounding desmo- a ‘plakin box’ but lacks the canonical actin-binding domain present somes, while the C-terminus of the protein binds intermediate in the N-terminus of some of the other family members [1]. filaments [1–3]. Notably, autoantibodies against periplakin and Although the crystal structure of periplakin N-terminus has not other plakin family members are found in patients with paraneo- been solved, it is likely to contain an array of individual spectrin- plastic pemphigus [4,5]. related domains that flank a central SH3 domain as seen in two During the epidermal differentiation, periplakin has a role in the other plakin family members, plectin and BPAG1 [11]. Transfection formation of cornified envelopes, the covalently cross-linked rem- studies have shown that the N-terminus is required for targeting of nants of cells that form a key component of the epidermal barrier periplakin and the dimer of periplakin and envoplakin to mem- [6,7]. Periplakin, together with envoplakin and involucrin, form brane locations [2]. Increased intracellular Calcium concentration has been suggested to play a role in the membrane targeting of ⇑ Corresponding author. Address: School of Biological and Biomedical Sciences, periplakin N-terminus [12] and known binding partners for the Durham University, South Road, Durham, DH1 3LE, United Kingdom. Fax: +44 191 N-terminus such as kazrin and plectin may influence the subcellu- 3341201. lar targeting of the complexes [13,14]. This said, the exact mecha- E-mail address: [email protected] (A. Määttä). nism of the targeting of periplakin to plasma membrane around 1 Present address: Institute of Genetic Medicine, Newcastle University, Interna- desmosomes and the full extent of periplakin interactions at cell tional Centre for Life, Central Parkway, Newcastle upon Tyne, NE1 3BZ, United Kingdom. border locations has not yet been revealed. 0014-5793/$36.00 Ó 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved. http://dx.doi.org/10.1016/j.febslet.2012.07.057 V. Boczonadi, A. Määttä / FEBS Letters 586 (2012) 3090–3096 3091 Annexins interact with phospholipids providing membrane- been described earlier [14]. 1-D separation of the immunoprecipi- organising functions in processes such as endocytosis, vesicle tated protein complexes was carried out with 4–12% gradient gels transport and membrane targeting [15,16]. The interactions be- (Invitrogen) followed by silver staining using Silver Snap Stain Kit tween annexins and membranes usually require Calcium ions. II (Pierce). Immunoprecipitation with anti-annexin and anti- The membrane-binding domain of annexins has a curved surface periplakin antibodies was carried out in cell-extracts that were that – in the presence of Calcium ions – docks onto phospholipid pre-cleared with protein-G agarose beads by incubating 1–3 ml membranes. Annexin family members have been shown to con- of protein extracts with 10 ll of antibody for 1 h at 4 °C on rocking tribute to epidermal biology. Both annexin A1 and A2 have been platform and then with Protein G beads at 4 °C on rocking plat- detected in epidermis [17]. Annexin A1 forms complexes with form. The immunoprecipitated complexes were washed 3 times S100A11 that is involved in the differentiation pathway induced in lysis buffer for 20 min at 4 °C. Immunoblotting of protein ex- by high Calcium levels. In addition, epidermal growth factor tracts and immunoprecipitated protein complexes and the subse- (EGF) induces cleavage of annexin A1 by cathepsin D at Trp12, quent detection by enhanced chemiluminescence was performed resulting in a loss of interaction with S100A11 [18]. Both annexin as described previously [14,22]. A1 and S100A11 are retained in corneocytes where they get cross-linked to cornified envelopes [19]. 2.4. Subcellular fractioning In this study we show that annexin A9 (also known as pemph- axin), an atypical annexin family member [20,21], co-immunopre- Cells were grown to confluence on 10 cm2 dishes and extracted cipitates with the periplakin N-terminus and co-localises with using saponin as described [22]. Briefly, the first extraction (S1 periplakin both at the lateral cell borders of simple epithelial fraction) was carried out with saponin buffer (0.01% w/v saponin, MCF-7 cells and in differentiating epidermal keratinocytes. 10 mM Tris pH 7.5, 140 mM NaCl, 5 mM EDTA, 2 mM EGTA, 1 mM PMSF (phenyl–methyl sulphonyl fluoride) and protease 2. Materials and methods inhibitor cocktail tablets (Roche) and the insoluble pellet was re- extracted using ice-cold Triton buffer (1% v/v TritonX-100, 2.1. Cell culture and transfections 10 mM Tris pH 7.5, 140 mM NaCl, 5 mM EDTA, 2 mM EGTA, 1 mM PMSF and protease inhibitor cocktail) to generate the S2 Human mammary adenocarcinoma cells (MCF-7) and HaCaT fraction and the Triton-insoluble fraction P fraction. All the sample keratinocytes were maintained in Dulbecco’s minimal essential volumes were adjusted to the same volume with 4Â LSB and equal media (DMEM Sigma, UK) supplemented with 10% foetal calf serum volumes were loaded on a 4–12% bis–Tris gel (Invitrogen) for anal- and 5% GPS (L-glutamine, glucose, penicillin, streptomycin). The ysis by immunoblotting. stably transfected cell lines expressing the pP1/2N construct and control (empty vector) transfected cell lines [14], the annexin A9- 3. Results GFP construct [20], and transient transfections using Lipofectamine [22] have been described earlier. Calcium-induced differentiation We utilised a co-immunoprecipitation approach in a MCF-7 of HaCaT cells was carried as described in [23] with a switch from subclone stably expressing HA-tagged periplakin N-terminus out- a low Calcium (0.06 mM) to high-Calcium (1.6 mM) culture med- lined in our previous publication [14] to identify protein com- ium. To induce a collapse of the intermediate filament cytoskeleton, plexes that contain periplakin and influence the subcellular the cells were treated with Okadaic Acid as described [22]. distribution and functions of this cytoskeletal linker protein. The over-expressed periplakin N-terminus is targeted to lateral cell 2.2. Immunofluorescence staining and confocal microscopy membranes of the MCF-7 subclone and shows a dominant negative effect by interfering with cytoskeletal organisation during epithe- Cells were grown on coverslips, fixed and blocked as described lial wound healing [14]. We chose to use simple epithelial cell sys- previously [22] and tissue sections
Recommended publications
  • Table 2. Significant
    Table 2. Significant (Q < 0.05 and |d | > 0.5) transcripts from the meta-analysis Gene Chr Mb Gene Name Affy ProbeSet cDNA_IDs d HAP/LAP d HAP/LAP d d IS Average d Ztest P values Q-value Symbol ID (study #5) 1 2 STS B2m 2 122 beta-2 microglobulin 1452428_a_at AI848245 1.75334941 4 3.2 4 3.2316485 1.07398E-09 5.69E-08 Man2b1 8 84.4 mannosidase 2, alpha B1 1416340_a_at H4049B01 3.75722111 3.87309653 2.1 1.6 2.84852656 5.32443E-07 1.58E-05 1110032A03Rik 9 50.9 RIKEN cDNA 1110032A03 gene 1417211_a_at H4035E05 4 1.66015788 4 1.7 2.82772795 2.94266E-05 0.000527 NA 9 48.5 --- 1456111_at 3.43701477 1.85785922 4 2 2.8237185 9.97969E-08 3.48E-06 Scn4b 9 45.3 Sodium channel, type IV, beta 1434008_at AI844796 3.79536664 1.63774235 3.3 2.3 2.75319499 1.48057E-08 6.21E-07 polypeptide Gadd45gip1 8 84.1 RIKEN cDNA 2310040G17 gene 1417619_at 4 3.38875643 1.4 2 2.69163229 8.84279E-06 0.0001904 BC056474 15 12.1 Mus musculus cDNA clone 1424117_at H3030A06 3.95752801 2.42838452 1.9 2.2 2.62132809 1.3344E-08 5.66E-07 MGC:67360 IMAGE:6823629, complete cds NA 4 153 guanine nucleotide binding protein, 1454696_at -3.46081884 -4 -1.3 -1.6 -2.6026947 8.58458E-05 0.0012617 beta 1 Gnb1 4 153 guanine nucleotide binding protein, 1417432_a_at H3094D02 -3.13334396 -4 -1.6 -1.7 -2.5946297 1.04542E-05 0.0002202 beta 1 Gadd45gip1 8 84.1 RAD23a homolog (S.
    [Show full text]
  • Cytoskeletal Linkers: New Maps for Old Destinations Megan K
    R864 Dispatch Cytoskeletal linkers: New MAPs for old destinations Megan K. Houseweart*† and Don W. Cleveland*†‡§ A new isoform of the actin–neurofilament linker protein as ‘bullous pemphigoid antigen’ (BPAG). These proteins BPAG has been found that binds to and stabilizes are large α-helical coiled-coil molecules which have axonal microtubules. This and other newly identified binding domains for one or more of the three cytoskele- microtubule-associated proteins are likely to be just the tal components (Figure 1). For example, the widely tip of an iceberg of multifunctional proteins that expressed, > 500 kD protein plectin has been shown to stabilize and crosslink cytoskeletal filament networks. associate with microtubules, intermediate filaments (glial fibrillary acidic protein, vimentin, keratins, all Addresses: *Ludwig Institute for Cancer Research, †Program in Biomedical Sciences, ‡Division of Cellular and Molecular Medicine and three neurofilament subunit proteins), actin, myosin and §Department of Neuroscience, University of California at San Diego, itself [3]. Given the widespread distribution and multi- La Jolla, California 92093, USA. ple interactions that are characteristic of these proteins, E-mail: [email protected] it is not surprising that a number of human and mouse Current Biology 1999, 9:R864–R866 diseases have been attributed to aberrant or missing cross-linking proteins [4]. 0960-9822/99/$ – see front matter © 1999 Elsevier Science Ltd. All rights reserved. This is the case for mice lacking the locus encoding the numerous isoforms of the essential ~280 kDa linker The cytoplasm of most eukaryotic cells contains a dynamic protein BPAG. Two neuronal isoforms of BPAG both have filamentous protein scaffold composed of 25 nm micro- a carboxy-terminal intermediate-filament-binding domain tubules, 4 nm actin filaments and 10 nm intermediate fila- and also an amino-terminal actin-binding region (Figure 1).
    [Show full text]
  • Method of Prognosing Cancers Verfahren Zur Prognose Von Krebsarten Procédé De Prognostic Des Cancers
    (19) TZZ Z _T (11) EP 2 295 602 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: G01N 33/574 (2006.01) C12Q 1/68 (2006.01) 11.07.2012 Bulletin 2012/28 (21) Application number: 10178350.4 (22) Date of filing: 26.07.2006 (54) Method of prognosing cancers Verfahren zur Prognose von Krebsarten Procédé de prognostic des cancers (84) Designated Contracting States: • KIHARA C ET AL: "Prediction of sensitivity of AT BE BG CH CY CZ DE DK EE ES FI FR GB GR esophageal tumors to adjuvant chemotherapy by HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI cDNA microarray analysis of gene-expression SK TR profiles", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, (30) Priority: 27.07.2005 US 703263 P BALTIMORE, MD, US, vol. 61, no. 17, September 2001 (2001-09), pages 6474-6479, XP002960719, (43) Date of publication of application: ISSN: 0008-5472 16.03.2011 Bulletin 2011/11 • PORTE H ET AL: "Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in (62) Document number(s) of the earlier application(s) in human esophageal carcinoma: implications for accordance with Art. 76 EPC: prognosis.", CLINICAL CANCER RESEARCH : 06782211.4 / 1 907 582 AN OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH. JUN (73) Proprietor: Oncotherapy Science, Inc. 1998, vol. 4, no. 6, June 1998 (1998-06), pages Kawasaki-shi 1375-1382, XP002407525, ISSN: 1078-0432 Kanagawa 213-0012 (JP) • "Affimetrix GeneChip Human Genome U133 Array Set HG-U133A", GEO, 11 March 2002 (72) Inventors: (2002-03-11), XP002254749, • Nakamura, Yusuke • WIGLE DENNIS A ET AL: "Molecular profiling of Tokyo 1138654 (JP) non-small cell lung cancer and correlation with • Daigo, Yataro disease-free survival", CANCER RESEARCH, Tokyo 1138654 (JP) AMERICAN ASSOCIATION FOR CANCER • Nakatsuru, Shuichi REREARCH, US, vol.
    [Show full text]
  • Microtubule-Actin Crosslinking Factor 1 and Plakins As Therapeutic Drug Targets
    Tennessee State University Digital Scholarship @ Tennessee State University Biology Faculty Research Department of Biological Sciences 1-26-2018 Microtubule-Actin Crosslinking Factor 1 and Plakins as Therapeutic Drug Targets Quincy A. Quick Tennessee State University Follow this and additional works at: https://digitalscholarship.tnstate.edu/biology_fac Part of the Pharmacology Commons Recommended Citation Quick, Q.A. Microtubule-Actin Crosslinking Factor 1 and Plakins as Therapeutic Drug Targets. Int. J. Mol. Sci. 2018, 19, 368. https://doi.org/10.3390/ijms19020368 This Article is brought to you for free and open access by the Department of Biological Sciences at Digital Scholarship @ Tennessee State University. It has been accepted for inclusion in Biology Faculty Research by an authorized administrator of Digital Scholarship @ Tennessee State University. For more information, please contact [email protected]. International Journal of Molecular Sciences Review Microtubule-Actin Crosslinking Factor 1 and Plakins as Therapeutic Drug Targets Quincy A. Quick Department of Biological Sciences, Tennessee State University, 3500 John A. Merritt Blvd, Nashville, TN 37209, USA; [email protected]; Tel.: +1-(615) 963-5768 Received: 11 December 2017; Accepted: 23 January 2018; Published: 26 January 2018 Abstract: Plakins are a family of seven cytoskeletal cross-linker proteins (microtubule-actin crosslinking factor 1 (MACF), bullous pemphigoid antigen (BPAG1) desmoplakin, envoplakin, periplakin, plectin, epiplakin) that network the three major filaments that comprise the cytoskeleton. Plakins have been found to be involved in disorders and diseases of the skin, heart, nervous system, and cancer that are attributed to autoimmune responses and genetic alterations of these macromolecules. Despite their role and involvement across a spectrum of several diseases, there are no current drugs or pharmacological agents that specifically target the members of this protein family.
    [Show full text]
  • Gene Expression Signatures and Biomarkers of Noninvasive And
    Oncogene (2006) 25, 2328–2338 & 2006 Nature Publishing Group All rights reserved 0950-9232/06 $30.00 www.nature.com/onc ORIGINAL ARTICLE Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: comprehensive profiles by representational difference analysis, microarrays and proteomics GM Nagaraja1, M Othman2, BP Fox1, R Alsaber1, CM Pellegrino3, Y Zeng2, R Khanna2, P Tamburini3, A Swaroop2 and RP Kandpal1 1Department of Biological Sciences, Fordham University, Bronx, NY, USA; 2Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USA and 3Bayer Corporation, West Haven, CT, USA We have characterized comprehensive transcript and Keywords: representational difference analysis; micro- proteomic profiles of cell lines corresponding to normal arrays; proteomics; breast carcinoma; biomarkers; breast (MCF10A), noninvasive breast cancer (MCF7) and copper homeostasis invasive breast cancer (MDA-MB-231). The transcript profiles were first analysed by a modified protocol for representational difference analysis (RDA) of cDNAs between MCF7 and MDA-MB-231 cells. The majority of genes identified by RDA showed nearly complete con- Introduction cordance withmicroarray results, and also led to the identification of some differentially expressed genes such The transformation of a normal cell into a cancer cell as lysyl oxidase, copper transporter ATP7A, EphB6, has been correlated to altered expression of a variety of RUNX2 and a variant of RUNX2. The altered transcripts genes (Perou et al., 2000; Becker et al., 2005). The identified by microarray analysis were involved in cell–cell expression of some of these genes is a direct result of or cell–matrix interaction, Rho signaling, calcium home- sequence mutation, whereas other changes occur due to ostasis and copper-binding/sensitive activities.
    [Show full text]
  • MALE Protein Name Accession Number Molecular Weight CP1 CP2 H1 H2 PDAC1 PDAC2 CP Mean H Mean PDAC Mean T-Test PDAC Vs. H T-Test
    MALE t-test t-test Accession Molecular H PDAC PDAC vs. PDAC vs. Protein Name Number Weight CP1 CP2 H1 H2 PDAC1 PDAC2 CP Mean Mean Mean H CP PDAC/H PDAC/CP - 22 kDa protein IPI00219910 22 kDa 7 5 4 8 1 0 6 6 1 0.1126 0.0456 0.1 0.1 - Cold agglutinin FS-1 L-chain (Fragment) IPI00827773 12 kDa 32 39 34 26 53 57 36 30 55 0.0309 0.0388 1.8 1.5 - HRV Fab 027-VL (Fragment) IPI00827643 12 kDa 4 6 0 0 0 0 5 0 0 - 0.0574 - 0.0 - REV25-2 (Fragment) IPI00816794 15 kDa 8 12 5 7 8 9 10 6 8 0.2225 0.3844 1.3 0.8 A1BG Alpha-1B-glycoprotein precursor IPI00022895 54 kDa 115 109 106 112 111 100 112 109 105 0.6497 0.4138 1.0 0.9 A2M Alpha-2-macroglobulin precursor IPI00478003 163 kDa 62 63 86 72 14 18 63 79 16 0.0120 0.0019 0.2 0.3 ABCB1 Multidrug resistance protein 1 IPI00027481 141 kDa 41 46 23 26 52 64 43 25 58 0.0355 0.1660 2.4 1.3 ABHD14B Isoform 1 of Abhydrolase domain-containing proteinIPI00063827 14B 22 kDa 19 15 19 17 15 9 17 18 12 0.2502 0.3306 0.7 0.7 ABP1 Isoform 1 of Amiloride-sensitive amine oxidase [copper-containing]IPI00020982 precursor85 kDa 1 5 8 8 0 0 3 8 0 0.0001 0.2445 0.0 0.0 ACAN aggrecan isoform 2 precursor IPI00027377 250 kDa 38 30 17 28 34 24 34 22 29 0.4877 0.5109 1.3 0.8 ACE Isoform Somatic-1 of Angiotensin-converting enzyme, somaticIPI00437751 isoform precursor150 kDa 48 34 67 56 28 38 41 61 33 0.0600 0.4301 0.5 0.8 ACE2 Isoform 1 of Angiotensin-converting enzyme 2 precursorIPI00465187 92 kDa 11 16 20 30 4 5 13 25 5 0.0557 0.0847 0.2 0.4 ACO1 Cytoplasmic aconitate hydratase IPI00008485 98 kDa 2 2 0 0 0 0 2 0 0 - 0.0081 - 0.0
    [Show full text]
  • Caspase 6 Disconnects Intermediate Filament-Binding Domain of Periplakin from Its Actin-Binding N-Terminal Region
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Breaking the Connection: Caspase 6 Disconnects Intermediate Filament-Binding Domain of Periplakin from its Actin-Binding N-Terminal Region Andrey E. Kalinin,Ã Alexandr E. Kalinin,Ã Mikko Aho,w Jouni Uitto,w and Sirpa Ahow ÃLaboratory of Skin Biology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA; wDepartment of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA Periplakin is a member of the plakin family of cytolinkers that connect cytoskeletal networks to each other as well as to the cell junctional complexes. Here, we demonstrate a direct molecular interaction between actin and pe- riplakin. Furthermore, the oligomerization state of periplakin was shown to determine specificity of its binding to intermediate filaments (IF) in vitro. Both the filament association and the cell membrane localization of periplakin were confirmed in the cells overexpressing human periplakin. Double labeling of the N- and C-terminally tagged periplakin revealed unexpected lack of co-localization of periplakin ends in a confluent culture, and separation of the periplakin ends was even more pronounced in apoptotic cells. Western analysis revealed that after induction of apoptosis, periplakin becomes cleaved close to its C-terminal tail. Only the distinct cleavage products, but not the full-length periplakin, were present in the cells detached from the solid support during the apoptotic process. We show that caspase 6 cleaves periplakin at an unconventional recognition site, amino acid sequence TVAD. Thus, the separation of periplakin ends disconnects the actin-binding head-rod domain from the IF-binding C-terminal domain.
    [Show full text]
  • Human Induced Pluripotent Stem Cell–Derived Podocytes Mature Into Vascularized Glomeruli Upon Experimental Transplantation
    BASIC RESEARCH www.jasn.org Human Induced Pluripotent Stem Cell–Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation † Sazia Sharmin,* Atsuhiro Taguchi,* Yusuke Kaku,* Yasuhiro Yoshimura,* Tomoko Ohmori,* ‡ † ‡ Tetsushi Sakuma, Masashi Mukoyama, Takashi Yamamoto, Hidetake Kurihara,§ and | Ryuichi Nishinakamura* *Department of Kidney Development, Institute of Molecular Embryology and Genetics, and †Department of Nephrology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; ‡Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, Japan; §Division of Anatomy, Juntendo University School of Medicine, Tokyo, Japan; and |Japan Science and Technology Agency, CREST, Kumamoto, Japan ABSTRACT Glomerular podocytes express proteins, such as nephrin, that constitute the slit diaphragm, thereby contributing to the filtration process in the kidney. Glomerular development has been analyzed mainly in mice, whereas analysis of human kidney development has been minimal because of limited access to embryonic kidneys. We previously reported the induction of three-dimensional primordial glomeruli from human induced pluripotent stem (iPS) cells. Here, using transcription activator–like effector nuclease-mediated homologous recombination, we generated human iPS cell lines that express green fluorescent protein (GFP) in the NPHS1 locus, which encodes nephrin, and we show that GFP expression facilitated accurate visualization of nephrin-positive podocyte formation in
    [Show full text]
  • “Deciphering the Genetic Architecture of Prolificacy Related Traits in an Experimental Iberian X Meishan F2 Intercross”
    UNIVERSITAT AUTÒNOMA DE BARCELONA Departament de Ciència Animal i dels Aliments Facultat de Veterinària “Deciphering the genetic architecture of prolificacy related traits in an experimental Iberian x Meishan F2 intercross” Ingrid Balcells Ortega PhD Thesis June, 2012 Supervisors: Armand Sánchez and Anna Tomás El Dr. Armand Sánchez Bonastre, catedràtic del Departament de Ciència Animal i dels Aliments de la Universitat Autònoma de Barcelona i la Dra. Anna Tomás Sangenís, investigadora en la Fundació d'Investigació Sanitària de les Illes Balears de Mallorca CERTIFIQUEN: Que l’Ingrid Balcells Ortega ha realitzat sota la seva direcció el treball de recerca “Deciphering the genetic architecture of prolificacy related traits in an experimental Iberian x Meishan F2 intercross” per a obtenir el grau de doctora per la Universitat Autònoma de Barcelona. Que aquest treball s’ha dut a terme al Departament de Ciència Animal i dels Aliments de la Facultat de Veterinària de la Universitat Autònoma de Barcelona. Bellaterra, 11 de Maig de 2012 Dr. Armand Sánchez Bonastre Dra. Anna Tomás Sangenís ACKNOWLEDGEMENTS Durant la realització d’aquesta tesi, han sigut moltes les persones que m’han acompanyat, tan a nivell professional com personal. Totes elles han aportat el seu granet de sorra per a que aquest projecte hagi tirat endavant i han fet que pugui recordar aquesta etapa amb un gran somriure a la cara. Als meus directors de tesi, el doctor Armand Sánchez i la doctora Anna Tomás. Per tota la confiança que heu dipositat en mi, per tots els coneixements que m’heu transmès, per donar-me copets a l’esquena en els moments de més desànim (sobretot en aquests últims mesos) i per mil coses més.
    [Show full text]
  • Subcellular Distribution of Envoplakin and Periplakin
    Subcellular Distribution of Envoplakin and Periplakin: Insights into Their Role as Precursors of the Epidermal Cornified Envelope Teresa DiColandrea, Tadashi Karashima, Arto Määttä, and Fiona M. Watt Keratinocyte Laboratory, Imperial Cancer Research Fund, London WC2A 3PX, England Abstract. Envoplakin and periplakin are two plakins moplakin, that of periplakin localized to desmosomes; that are precursors of the epidermal cornified envelope. however, in addition, the periplakin NH2 terminus ac- We studied their distribution and interactions by trans- cumulated at cell surface microvilli in association with fection of primary human keratinocytes and other cells. cortical actin. Endogenous periplakin was redistributed Full-length periplakin localized to desmosomes, the in- from microvilli when keratinocytes were treated with terdesmosomal plasma membrane and intermediate the actin disrupting drug Latrunculin B. We propose filaments. Full length envoplakin also localized to des- that whereas envoplakin and periplakin can localize in- mosomes, but mainly accumulated in nuclear and cyto- dependently to desmosomes, the distribution of en- plasmic aggregates with associated intermediate fila- voplakin at the interdesmosomal plasma membrane de- ments. The envoplakin rod domain was required for pends on heterodimerization with periplakin and that aggregation and the periplakin rod domain was neces- the NH2 terminus of periplakin therefore plays a key sary and sufficient to redistribute envoplakin to desmo- role in forming the scaffold on which the cornified
    [Show full text]
  • Fibroblasts from the Human Skin Dermo-Hypodermal Junction Are
    cells Article Fibroblasts from the Human Skin Dermo-Hypodermal Junction are Distinct from Dermal Papillary and Reticular Fibroblasts and from Mesenchymal Stem Cells and Exhibit a Specific Molecular Profile Related to Extracellular Matrix Organization and Modeling Valérie Haydont 1,*, Véronique Neiveyans 1, Philippe Perez 1, Élodie Busson 2, 2 1, 3,4,5,6, , Jean-Jacques Lataillade , Daniel Asselineau y and Nicolas O. Fortunel y * 1 Advanced Research, L’Oréal Research and Innovation, 93600 Aulnay-sous-Bois, France; [email protected] (V.N.); [email protected] (P.P.); [email protected] (D.A.) 2 Department of Medical and Surgical Assistance to the Armed Forces, French Forces Biomedical Research Institute (IRBA), 91223 CEDEX Brétigny sur Orge, France; [email protected] (É.B.); [email protected] (J.-J.L.) 3 Laboratoire de Génomique et Radiobiologie de la Kératinopoïèse, Institut de Biologie François Jacob, CEA/DRF/IRCM, 91000 Evry, France 4 INSERM U967, 92260 Fontenay-aux-Roses, France 5 Université Paris-Diderot, 75013 Paris 7, France 6 Université Paris-Saclay, 78140 Paris 11, France * Correspondence: [email protected] (V.H.); [email protected] (N.O.F.); Tel.: +33-1-48-68-96-00 (V.H.); +33-1-60-87-34-92 or +33-1-60-87-34-98 (N.O.F.) These authors contributed equally to the work. y Received: 15 December 2019; Accepted: 24 January 2020; Published: 5 February 2020 Abstract: Human skin dermis contains fibroblast subpopulations in which characterization is crucial due to their roles in extracellular matrix (ECM) biology.
    [Show full text]
  • Adaptor Periplakin Phosphoantigens and the Cytoskeletal Interactions Of
    Activation of Human δγ T Cells by Cytosolic Interactions of BTN3A1 with Soluble Phosphoantigens and the Cytoskeletal Adaptor Periplakin This information is current as of October 1, 2021. David A. Rhodes, Hung-Chang Chen, Amanda J. Price, Anthony H. Keeble, Martin S. Davey, Leo C. James, Matthias Eberl and John Trowsdale J Immunol published online 30 January 2015 http://www.jimmunol.org/content/early/2015/01/30/jimmun Downloaded from ol.1401064 Supplementary http://www.jimmunol.org/content/suppl/2015/01/30/jimmunol.140106 Material 4.DCSupplemental http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on October 1, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2015 The Authors All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published January 30, 2015, doi:10.4049/jimmunol.1401064 The Journal of Immunology Activation of Human gd T Cells by Cytosolic Interactions of BTN3A1 with Soluble Phosphoantigens and the Cytoskeletal Adaptor Periplakin David A. Rhodes,* Hung-Chang Chen,†,1 Amanda J. Price,‡,1 Anthony H.
    [Show full text]